- N. Anichkov, Department of Pathology and Physiology, Academy of Medical Sciences, Leningrad, USSR
- Atta-ur Rahman, International Center for Chemical and Biological Sciences, University of Karachi
- J. Axelrod, National Institute of Mental health, Bethesda MD 20892, USA
- W. Birkmayer, Evangelica Hospital, Vienna, Austria
- T B. Bolton, Ion Channels &Cell Signaling, Basic Medical Sciences,St George’s University of London
- A. F Brading, University Department of Pharmacology, Oxford
- G. Burnstock, Autonomic Neuroscience Institute, Royal Free Hospital, School of Medicine, London
- B. Cuparencu, Disciplina de Farmakologie a IMF Cluj-Napoca, Cluj-Napoca, Romania
- C. T Dollery, Department of Medicine, University of London, London, UK,
- S. Ehrenpreis, UHS/The Chicago Medical School, North Chicago, USA
- L. Endrényi, Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
- F. Erjavec, Department of Pharmacology, Medical Faculty, University of Ljubljana, Yugoslavia
- S. Fern, Institute of Pharmacology, University of Bologna, Bologna, Italy
- G. Feszt, Department of Pharmacology, Medical and Pharmaceutical Institute Tirgu-Mures, Tirgu-Mures, Romania
- W. Förster, Department of Pharmacology and Toxicology, Mertin-Luther University, Halle-Wittenberg, GDR
- R. B. Furchgott, Department of Pharmacology, Sunny Health Science Center of Brooklyn, NY 11203, USA
- V. P. Georgiev, Institute of Physiologiy, Bulgarian Academy of Sciences, Sofia, Bulgaria
- V. Z. Gorkin, Institute of Biological and Medical Chemsitry, Academy of Medical Sciences, Moscow, USSR
- T. Griesbaclier, Institut für ExperrnentcHe und Klinische Pharinakologie der Medizinischen Universitat, Graz, Austria
- R. J. Gryglewski, Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland
- P. Holzer Institut für Experimentelle und Klinische Pharmakologie der Medizinischen Universität Graz, Graz, Austria
- S. Hukovic, Department of Pharmacology, Medical Faculty, Sarajevo, Yugoslavia
- J. R. Idle, Institute for Cancer Research and Molecular Biology, MediL I Technical Research Centre, Norwegian University of Science and Technolog\ Trondheim, Norway
- P. Illés, Leipzig, Germany
- H. Iwata, Department of Pharmacology, Faculty of Pharmaceutical Sciences. Osaka University, Osaka, Japan
- N. V. Kaverina, Institute of Pharmacology, Academy of Medical Scienc of the USSR, Moscow, USSR
- D. A. Kharkevich, 1st Medical Institute, Moscow, USSR
- I. P. Lapin, Laboratory of Psychopharmacology, Bekhterey Psychoneuro1 gical Research Institute, Leningrad, USSR
- J. Maj, Institute of Pharmacology, Polish Academy of Sciences, Krako’ Poland
- F. Markward, Institute of Pharmacology and Toxicology, Medical Acaden Erfurt, Erfurt, GDR
- M. Nagano, Department of internal Medicine, Jikei University School of M dicine, Katsushuka-ku, Tokyo, Japan
- S. Okabe, Department of Pharmacology, Doshisha University, Kyoto
- M. K. Paasonen, Department of Pharmacology, University of Helsinki, 1k sinki, Finland
- P. Pacher Laboratory of Physiologic Studies National Institute on Alcoh Abuse and Alcoholism, Bethesda, USA
- R. Paoletti, Institute of Pharmacological Scieces, University of Milan, M Ian, Italy
- J. R. Parratt, Department of Physiology and Pharmacology, Strathcly Insitute for Biomedical Sciences, University of Strathclyde, Glasgow, S land, UK
- V. Petkov, Institute of Physiologiy, Bulgarian Academy of Sciences, Bulgaria
- G. Petroianu, Department of Pharmacology and Therapeutics, Faculty of dicine & Health Sciences, United Arab Emirates University, Al Am
- K. D. Rainsford, Biomedical Research Centre, Sheffield Hallam Univ’i Sheffield, UK
- H. Rang, Novartis Institute for Medical Research, London
- H. Raskova, Institute of Pharmacology, Czechoslovak Academy of SCkIG Prague, Czechoslovakia
- K. S. Ravevski, 1)cpart i twill of Pharmacology, Academy of Medical Sciences, Moscow, USSR
- P. Riederer, Department ol Psychiatry, Clinical Neurochemistry, Wiirzhurg P Ro,nuaidi, Department of Pharmacology, University of Bologna, Bologna, Italy
- M. Sandier, Bernhard Baron memorial research Laboratories and Insitute of Obstetrics and Gynecology, Queen Charlotte’s Hospital, London UK
- M. Schafer, Department of Anesthesiology and Intensive Care Medicine, Charite University Berlin
- A. Schwartz, Institute of Molecular Pharmacology and Biophysics, University of Cincinnati College of Medicine, USA
- V. P. Shah, VSP Consulting, LLC, Pharmaceutical Consultant, North Potomac, USA; University of Kentucky, Lexington, USA
- Th. P. Singer, Department of Pharmaceutical Chemistry, Biochemistry and Biophysics, University of California, San Francisco, USA
- F. Sjoqvist, Department of Clinical Pharmacology, Huddinge University Hospital, Stockholm
- K. Starke, Die Geschichte des Pharmakologischen Instituts der Universität Freiburg
- S. Szabo, School of Medicine, University of California
- K. F. Tipton, Department of Pharmacology, Trinity College, Dublin, Ireland U. Trendeienburg, Department of Pharmacology, University of Wurzburg, Wurzburg, Germany
- B. Uvnas, Department of Pharmacology Karoliniska Institute, Stockholm, Sweeden
- D. F. van Heiden, The Neuroscience Group, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, New South Wales, Australia
- V. M. Varagic, Department of Pharmacology, Medical Faculty, Belgrade, Yugoslavia
- E. M. Vaughan, Williams Hertford College, Oxford, UK
- G. Veio, Department of Pharmacology, University of Verona
- B. Vrhovac, Division of Clinical Pharmacology, Department of Medicine, Clinical Hospital Centre, Medical School of Zagreb
- A. Woiienberger Division of Cellular and Molecular Cardiology, central Insitute for Cardiovascular Research, Academy of Sciences of the GDR, BerlinBuch, GDR
- V. V. Zakusov, Institute of Pharmacology, Academy of Medical Sciences of the USSR, Moscow, USSR
